Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127459021 | 12745902 | 1 | I | 20160815 | 20160902 | 20160915 | 20160915 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN128820 | GLAXOSMITHKLINE | 61.00 | YR | M | Y | 51.00000 | KG | 20160915 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127459021 | 12745902 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 25 MG, BID | 2550 | MG | Y | 20241 | 25 | MG | TABLET | BID | |||
127459021 | 12745902 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, QD | 2550 | MG | Y | 20241 | 100 | MG | TABLET | QD | |||
127459021 | 12745902 | 3 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, BID | 2550 | MG | Y | 20241 | 100 | MG | TABLET | BID | |||
127459021 | 12745902 | 4 | C | QUETIAPINE. | QUETIAPINE | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
127459021 | 12745902 | 5 | C | BELSOMRA | SUVOREXANT | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
127459021 | 12745902 | 6 | C | SENNOSIDE | SENNOSIDES | 1 | 36 MG, QD | 0 | 36 | MG | QD | ||||||||
127459021 | 12745902 | 7 | C | TEGRETOL | CARBAMAZEPINE | 1 | 100 MG, BID | 0 | 100 | MG | BID | ||||||||
127459021 | 12745902 | 8 | C | MAGLAX | MAGNESIUM OXIDE | 1 | 330 MG, TID | 0 | 330 | MG | TID | ||||||||
127459021 | 12745902 | 9 | C | PANTOSIN | PANTETHINE | 1 | 100 MG, TID | 0 | 100 | MG | TID | ||||||||
127459021 | 12745902 | 10 | C | GOREISAN | HERBALS | 1 | UNK UNK, TID | 0 | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127459021 | 12745902 | 1 | Partial seizures |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127459021 | 12745902 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127459021 | 12745902 | Drug eruption | |
127459021 | 12745902 | Hepatic function abnormal | |
127459021 | 12745902 | Pyrexia | |
127459021 | 12745902 | Rash erythematous | |
127459021 | 12745902 | Rash pruritic | |
127459021 | 12745902 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127459021 | 12745902 | 1 | 20160715 | 20160728 | 0 | |
127459021 | 12745902 | 2 | 20160729 | 20160811 | 0 | |
127459021 | 12745902 | 3 | 20160812 | 20160815 | 0 |